RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Jianying Zhang to Autoantibodies

This is a "connection" page, showing publications Jianying Zhang has written about Autoantibodies.
Connection Strength

8.180
  1. Ma Y, Qiu C, Wang B, Zhang X, Wang X, Aguilera RJ, Zhang JY. Autoantibody against Tumor-Associated Antigens as Diagnostic Biomarkers in Hispanic Patients with Hepatocellular Carcinoma. Cells. 2022 10 14; 11(20).
    View in: PubMed
    Score: 0.797
  2. Dai L, Tsay JC, Li J, Yie TA, Munger JS, Pass H, Rom WN, Zhang Y, Tan EM, Zhang JY. Autoantibodies against tumor-associated antigens in the early detection of lung cancer. Lung Cancer. 2016 09; 99:172-9.
    View in: PubMed
    Score: 0.517
  3. Li J, Dai L, Lei N, Xing M, Li P, Luo C, Casiano CA, Zhang JY. Evaluation and characterization of anti-RalA autoantibody as a potential serum biomarker in human prostate cancer. Oncotarget. 2016 Jul 12; 7(28):43546-43556.
    View in: PubMed
    Score: 0.517
  4. Zhou JW, Li Y, Yue LX, Luo CL, Chen Y, Zhang JY. Autoantibody response to Sui1 and its tissue-specific expression in hepatocellular carcinoma. Tumour Biol. 2016 Feb; 37(2):2547-53.
    View in: PubMed
    Score: 0.488
  5. Liu Y, Dai L, Liu W, Shi G, Zhang J. Autoantibody to MDM2: A Potential Serological Marker of Systemic Lupus Erythematosus. J Immunol Res. 2015; 2015:963568.
    View in: PubMed
    Score: 0.477
  6. Zhu Q, Han SX, Zhou CY, Cai MJ, Dai LP, Zhang JY. Autoimmune response to PARP and BRCA1/BRCA2 in cancer. Oncotarget. 2015 May 10; 6(13):11575-84.
    View in: PubMed
    Score: 0.476
  7. Liu M, Varela-Ramirez A, Li J, Dai L, Aguilera RJ, Zhang JY. Humoral autoimmune response to nucleophosmin in the immunodiagnosis of hepatocellular carcinoma. Oncol Rep. 2015 May; 33(5):2245-52.
    View in: PubMed
    Score: 0.471
  8. Li Y, Zhang Q, Peng B, Shao Q, Qian W, Zhang JY. Identification of glutathione S-transferase omega 1 (GSTO1) protein as a novel tumor-associated antigen and its autoantibody in human esophageal squamous cell carcinoma. Tumour Biol. 2014 Nov; 35(11):10871-7.
    View in: PubMed
    Score: 0.452
  9. Liu M, Zheng SJ, Chen Y, Li N, Ren PF, Dai LP, Duan ZP, Zhang JY. Autoantibody response to murine double minute 2 protein in immunodiagnosis of hepatocellular carcinoma. J Immunol Res. 2014; 2014:906532.
    View in: PubMed
    Score: 0.445
  10. Liu X, Ye H, Li L, Li W, Zhang Y, Zhang JY. Humoral autoimmune responses to insulin-like growth factor II mRNA-binding proteins IMP1 and p62/IMP2 in ovarian cancer. J Immunol Res. 2014; 2014:326593.
    View in: PubMed
    Score: 0.443
  11. Dai L, Li J, Ortega R, Qian W, Casiano CA, Zhang JY. Preferential autoimmune response in prostate cancer to cyclin B1 in a panel of tumor-associated antigens. J Immunol Res. 2014; 2014:827827.
    View in: PubMed
    Score: 0.442
  12. Dai L, Ren P, Liu M, Imai H, Tan EM, Zhang JY. Using immunomic approach to enhance tumor-associated autoantibody detection in diagnosis of hepatocellular carcinoma. Clin Immunol. 2014 May-Jun; 152(1-2):127-39.
    View in: PubMed
    Score: 0.440
  13. Zhang JY, Tan EM. Autoantibodies to tumor-associated antigens as diagnostic biomarkers in hepatocellular carcinoma and other solid tumors. Expert Rev Mol Diagn. 2010 Apr; 10(3):321-8.
    View in: PubMed
    Score: 0.334
  14. Chen Y, Zhou Y, Qiu S, Wang K, Liu S, Peng XX, Li J, Tan EM, Zhang JY. Autoantibodies to tumor-associated antigens combined with abnormal alpha-fetoprotein enhance immunodiagnosis of hepatocellular carcinoma. Cancer Lett. 2010 Mar 01; 289(1):32-9.
    View in: PubMed
    Score: 0.320
  15. Looi K, Megliorino R, Shi FD, Peng XX, Chen Y, Zhang JY. Humoral immune response to p16, a cyclin-dependent kinase inhibitor in human malignancies. Oncol Rep. 2006 Nov; 16(5):1105-10.
    View in: PubMed
    Score: 0.264
  16. Zhang JY. Mini-array of multiple tumor-associated antigens to enhance autoantibody detection for immunodiagnosis of hepatocellular carcinoma. Autoimmun Rev. 2007 Jan; 6(3):143-8.
    View in: PubMed
    Score: 0.263
  17. Zhang JY. Tumor-associated antigen arrays to enhance antibody detection for cancer diagnosis. Cancer Detect Prev. 2004; 28(2):114-8.
    View in: PubMed
    Score: 0.217
  18. Qiu C, Ma Y, Wang B, Zhang X, Wang X, Zhang JY. Autoantibodies to PAX5, PTCH1, and GNA11 as Serological Biomarkers in the Detection of Hepatocellular Carcinoma in Hispanic Americans. Int J Mol Sci. 2023 Feb 13; 24(4).
    View in: PubMed
    Score: 0.204
  19. Sanchez TW, Zhang G, Li J, Dai L, Mirshahidi S, Wall NR, Yates C, Wilson C, Montgomery S, Zhang JY, Casiano CA. Immunoseroproteomic Profiling in African American Men with Prostate Cancer: Evidence for an Autoantibody Response to Glycolysis and Plasminogen-Associated Proteins. Mol Cell Proteomics. 2016 Dec; 15(12):3564-3580.
    View in: PubMed
    Score: 0.131
  20. Dai L, Li J, Xing M, Sanchez TW, Casiano CA, Zhang JY. Using Serological Proteome Analysis to Identify Serum Anti-Nucleophosmin 1 Autoantibody as a Potential Biomarker in European-American and African-American Patients With Prostate Cancer. Prostate. 2016 11; 76(15):1375-86.
    View in: PubMed
    Score: 0.129
  21. Peng B, Chai Y, Li Y, Liu X, Zhang J. CIP2A overexpression induces autoimmune response and enhances JNK signaling pathway in human lung cancer. BMC Cancer. 2015 Nov 11; 15:895.
    View in: PubMed
    Score: 0.123
  22. Li Y, Francia G, Zhang JY. p62/IMP2 stimulates cell migration and reduces cell adhesion in breast cancer. Oncotarget. 2015 Oct 20; 6(32):32656-68.
    View in: PubMed
    Score: 0.123
  23. Zhu Q, Liu M, Dai L, Ying X, Ye H, Zhou Y, Han S, Zhang JY. Using immunoproteomics to identify tumor-associated antigens (TAAs) as biomarkers in cancer immunodiagnosis. Autoimmun Rev. 2013 Oct; 12(12):1123-8.
    View in: PubMed
    Score: 0.105
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support